J147 treatment protects against traumatic brain injury by inhibiting neuronal endoplasmic reticulum stress potentially via the AMPK/SREBP-1 pathway
Translational Research · 2024-12 · 274 · 21-34
DOI: 10.1016/j.trsl.2024.08.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Research, 2024-12. Verfasst von Rong Jin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Penn State Hershey Medical Center, Hershey, PA 17033, USA. Electronic address: Rjin@pennstatehealth.psu.edu. Hauptthemen laut MEDLINE: Endoplasmic Reticulum Stress, Brain Injuries, Traumatic, Neurons, Signal Transduction. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Endoplasmic reticulum (ER) stress is recognized as a crucial contributor to the progression of traumatic brain injury (TBI) and represents a potential target for therapeutic intervention. This study aimed to assess the potential of J147, a novel neurotrophic compound, in alleviating ER stress by modulating related signaling pathways, thereby promoting functional recovery in TBI. To this end, adult mice underwent controlled cortical impact (CCI) injury to induce TBI, followed by oral administration of J147 one-hour post-injury, with daily dosing for 3 to 7 days. Multiple behavioral assessments were conducted over 35 days, revealing a significant, dose-dependent improvement in neurofunctional recovery with J147 treatment. The neuropathological analysis demonstrated reduced acute neurodegeneration (observed at three days through FJC staining), enhanced long-term neuron survival (H&E and Nissl staining), and improved neuroplasticity (Golgi staining) at 35 days post-TBI. At the molecular level, TBIinduced AMP-activated protein kinase (AMPK) dephosphorylation, sterol regulatory element binding protein-1 (SREBP-1) activation, and upregulation of ER stress marker proteins, including phosphorylated eukaryotic initiation factor-2α (p-eIF2a), activating transcription factor 4 (ATF4), and C/EBP homologous protein (CHOP) in perilesional cortex neurons at three days post-injury. Notably, the J147 treatment significantly attenuated AMPK dephosphorylation, SERBP-1 activation, and expression of the ER stress markers. In summary, this study reveals the therapeutic promise of J147 in mitigating secondary brain damage associated with TBI and improving long-term functional recovery by modulating ER stress pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Penn State Hershey Medical Center, Hershey, PA 17033, USA. Electronic address: Rjin@pennstatehealth.psu.edu.
- Department of Neurosurgery, Penn State Hershey Medical Center, Hershey, PA 17033, USA.
- Department of Biomedical Engineering, Pennsylvania State University; University Park, PA, 16802, USA.
- Department of Neurosurgery, Penn State Hershey Medical Center, Hershey, PA 17033, USA. Electronic address: Guohongli@pennstatehealth.psu.edu.
Förderung
- NINDS NIH HHS
- National Institutes of Health
Zitieren
APA
Jin, R., Wang, M., Shukla, M., Lei, Y., An, D., Du, J., & Li, G. (2024). J147 treatment protects against traumatic brain injury by inhibiting neuronal endoplasmic reticulum stress potentially via the AMPK/SREBP-1 pathway. Translational Research, 274, 21-34. https://doi.org/10.1016/j.trsl.2024.08.007
Vancouver
Jin R, Wang M, Shukla M, Lei Y, An D, Du J, et al. J147 treatment protects against traumatic brain injury by inhibiting neuronal endoplasmic reticulum stress potentially via the AMPK/SREBP-1 pathway. Translational Research. 2024;274:21-34. doi:10.1016/j.trsl.2024.08.007
BibTeX
@article{Jin2024,
author = {Jin, Rong and Wang, Min and Shukla, Manish and Lei, Yuguo and An, Dong and Du, Jiwen and Li, Guohong},
title = {J147 treatment protects against traumatic brain injury by inhibiting neuronal endoplasmic reticulum stress potentially via the AMPK/SREBP-1 pathway},
journal = {Translational Research},
year = {2024},
volume = {274},
pages = {21--34},
doi = {10.1016/j.trsl.2024.08.007}
}
EUVIMED